---
document_datetime: 2025-12-18 09:54:11
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/mepact-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: mepact-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.8544758
conversion_datetime: 2026-01-03 12:28:02.798655
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Mepact

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number     | Scope                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|------------------------|-----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IA_IN / | B.II.b.2.c Replacement or addition of a | 18/12/2025                          |                                             | Annex II and                     |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                                         | manufacturer responsible for importation and/or batch release - B.II.b.2.c.1 Not including batch control/testing - Accepted                                                                                                                                                                                                                                                                                                                                    |            |            | PL                     | EMA/VR/0000319446   |
|---------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------|
| Marketing Authorisation Transfer - H / EMA/T/0000301999 | - Transfer of a marketing authorisation - transfer of marketing authorisation from Takeda France S.A.S. to Esteve Pharmaceuticals S.A.                                                                                                                                                                                                                                                                                                                         | 17/10/2025 | 26/11/2025 | SmPC, Labelling and PL |                     |
| Variation type IB / EMA/VR/0000286228                   | This was an application for a group of variations. B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.z Other changes - Accepted B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.z Other changes - Accepted B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.z Other changes - Accepted | 20/08/2025 | N/A        |                        |                     |
| Variation type IB /                                     | B.I.b.1 Change in the specification parameters and/or limits of an active substance, starting material / intermediate / reagent used in the manufacturing process                                                                                                                                                                                                                                                                                              | 07/08/2025 | N/A        |                        | EMA/VR/0000287273   |

<div style=\"page-break-after: always\"></div>

|                                          | of the active substance - B.I.b.1.z Other changes - Accepted                                                                                                                                                                                                                                                   |            |            |                        |
|------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| Variation type IB / EMA/VR/0000287022    | B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.z Other variation - Accepted                                                                                                                                                                                                    | 04/08/2025 | N/A        |                        |
| Variation type IA_IN / EMA/VR/0000282421 | A. ADMINISTRATIVE CHANGES - A.1 Change in the name and/or address of the marketing authorisation holder - Accepted                                                                                                                                                                                             | 11/07/2025 | 26/11/2025 | SmPC, Labelling and PL |
| Variation type IA / EMA/VR/0000284952    | B.I.b.1 Change in the specification parameters and/or limits of an active substance, starting material / intermediate / reagent used in the manufacturing process of the active substance - B.I.b.1.d Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) - Refused | 10/07/2025 | N/A        |                        |